23 - 25 July, 2018 | Sheraton Philadelphia University City Hotel, Philadelphia, PA

Meet the Advisory Board and Speakers

Advisory Board

Ramana Sonty
Director, Global Medical Organization
Johnson & Johnson

Anne B. Cropp
Chief Scientific Officer
Early Access Care, LLC

Brian J. Malkin
FDA Counsel
Arent Fox LLP

Beth E. Roxland
Senior Consultant on Law, Policy, and Ethics; Associate Division of Medical Ethics
NYU Langone School of Medicine

Jennifer McNary
Patient Advocate
Beauhawks Foundation

Andrew McFadyen
Executive Director
The Isaac Foundation

Frank Burroughs
CEO
Abigail Alliance for Better Access to Developmental Drugs

Tom Watson
Pre-approval Access Consultant
TW Consulting Group

Kevin J. Weatherwax
Administrative Program Director; Co-Chair - Expanded Access Oversight Committee
University of Michigan Health System

Stephen Rosenfeld
Executive Board Chair
Quorum Review IRB

Ramana Sonty
Director, Global Medical Organization
Johnson & Johnson

Anne B. Cropp
Chief Scientific Officer
Early Access Care

Beverly Harrison
Head, Patient Support
Johnson and Johnson

Karen Bartels
Director, Global Medical Affairs, Early Clinical Development and External Research
AstraZeneca

Timothy M Miller
VP & Head, North America Medical Affairs, Rare Diseases
Sanofi Genzyme

Alison Bateman-House
Assistant Professor – Division of Medical Ethics
NYU

June Wasser
Executive Director and CEO
Reagan-Udall Foundation for the FDA

Marjorie Speers
Executive Director
WCG Foundation

Luiz Andre Magno
Global Medical Affairs Leader - Neuroscience
Janssen Pharmaceutical

Jennifer McNary
Patient Advocate
Beauhawks Foundation

Kevin J. Weatherwax
Administrative Program Director; Co-Chair - Expanded Access Oversight Committee
University of Michigan Health System